Why choose KromaTiD?

We mitigate risks by leveraging our experienced technical team, trusted for years in conducting thorough genomic integrity analyses of cell and gene therapy drug products. Our expert services actively support advancements in cell and gene therapy.

Our journey began with high resolution dGH chromatid paints. Originally used by NASA in the “Twins Study” to study genomic responses to spaceflight, dGH™ assesses structural rearrangements caused by any mechanism.

Today, dGH™ remains vital, enabling direct analysis of genomic integrity and identifying complex structural rearrangements missed by PCR and sequencing platforms. Trusted by NASA for ongoing research, it supports your therapeutic research success from discovery to clinical trials.